|
KIAA0020 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.89009999998591E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.558200E-04 |
| Normal-vs-Stage2 |
1.1720999999465E-06 |
| Normal-vs-Stage3 |
2.042900E-04 |
| Normal-vs-Stage4 |
5.369400E-04 |
| Stage1-vs-Stage2 |
3.940900E-03 |
| Stage1-vs-Stage3 |
3.659400E-01 |
| Stage1-vs-Stage4 |
4.032600E-01 |
| Stage2-vs-Stage3 |
5.854100E-02 |
| Stage2-vs-Stage4 |
8.892200E-02 |
| Stage3-vs-Stage4 |
9.125400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.65699999999625E-05 |
| Normal-vs-AfricanAmerican |
3.404400E-03 |
| Normal-vs-Asian |
2.177600E-02 |
| Caucasian-vs-AfricanAmerican |
6.164200E-01 |
| Caucasian-vs-Asian |
5.994000E-01 |
| AfricanAmerican-vs-Asian |
4.010800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.18779999969921E-07 |
| Normal-vs-Female |
5.65969999999361E-05 |
| Male-vs-Female |
8.123800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.316500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.44049999986728E-07 |
| Normal-vs-Age(61-80Yrs) |
1.51110000001786E-06 |
| Normal-vs-Age(81-100Yrs) |
2.739600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.343900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.524000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.719800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.723200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.317800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.426000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.053000E-01 |
| Classical-VS-Follicular |
1.03690000030632E-07 |
| Classical-VS-Other |
2.373600E-01 |
| Classical-VS-Normal |
2.338900E-03 |
| Tall-VS-Follicular |
7.190000E-04 |
| Tall-VS-Other |
2.228600E-01 |
| Tall-VS-Normal |
2.639600E-01 |
| Follicular-VS-Other |
5.887400E-01 |
| Follicular-VS-Normal |
3.56299989512365E-10 |
| Other-VS-Normal |
1.253560E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.93550000657939E-09 |
| Normal-vs-N1 |
9.248600E-04 |
| N0-vs-N1 |
3.618800E-01 |
|
|
